Form 8-K - Current report:
SEC Accession No. 0000950170-24-139569
Filing Date
2024-12-23
Accepted
2024-12-23 16:05:08
Documents
12
Period of Report
2024-12-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-20241223.htm   iXBRL 8-K 61907
2 EX-99.1 hrtx-ex99_1.htm EX-99.1 9190
  Complete submission text file 0000950170-24-139569.txt   224058

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hrtx-20241223.xsd EX-101.SCH 49739
14 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20241223_htm.xml XML 6178
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 241573586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)